Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic inflammation and COPD: the Framingham Heart Study.

Robert E Walter1, Jemma B Wilk, Martin G Larson

  • 1Section of Pulmonary, Allergy, and Critical Care Medicine, Boston University School of Medicine, Boston, MA 02118, USA. walterb@bu.edu

Chest
|October 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Circulation·2017
Same author

Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study.

Stroke·2017
Same author

Relations Between Aortic Stiffness and Left Ventricular Mechanical Function in the Community.

Journal of the American Heart Association·2017
Same author

Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study.

Scientific reports·2017
Same author

2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Journal of the American College of Cardiology·2016
Same author

2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Circulation. Cardiovascular quality and outcomes·2016

Systemic inflammation, indicated by biomarkers like IL-6, is linked to reduced lung function and increased COPD risk. These findings highlight inflammation's role in pulmonary dysfunction, even in non-smokers.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Cardiovascular Research

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) pathogenesis involves local inflammation.
  • Systemic inflammatory biomarkers may contribute to impaired lung function.

Purpose of the Study:

  • To investigate the association between systemic inflammatory biomarkers and lung function.
  • To explore this relationship in the context of smoking history.

Main Methods:

  • Cross-sectional analysis of Framingham Heart Study data.
  • Examined biomarkers: CD40L, ICAM-1, IL-6, MCP-1, P-selectin, myeloperoxidase, CRP.
  • Assessed associations with lung function (FEV1) and COPD prevalence.

Main Results:

Related Experiment Videos

  • Interleukin-6 (IL-6) strongly correlated with lower FEV1 and increased COPD odds.
  • P-selectin also associated with reduced FEV1.
  • ICAM-1 and CD40L showed significant associations with FEV1 and COPD, particularly in heavy smokers.

    • Conclusions:

    • Systemic inflammation is associated with diminished pulmonary function.
    • Further research is warranted on systemic inflammation's role in pulmonary dysfunction.